Big Pharma taking steps towards fully digital businesses
December 3, 2015Medical Communications Accenture, digital pharma, innovation
Pharma companies can tap into $100 billion of revenue from being ‘digital transformers’, and not just ‘digital followers’, a leading …
Chief scientific officers appointed at dementia Drug Discovery Alliance
December 3, 2015Medical Communications, Research and Development Alzheimer's Research, dementia, dementia drug discovery alliance
Alzheimer’s Research UK has appointed three chief scientific officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites …
Katja Stout joins Citigate Dewe Rogerson as director
December 3, 2015Medical Communications Citigate Dewe Rogerson
Citigate Dewe Rogerson has appointed of Katja Stout (previously Toon) as a director in its life sciences team. Katja is …
Alkermes aims to take the next biotech step
December 3, 2015Medical Communications, Research and Development Alkermes
“We think we can be the next Biogen, or a Celgene or a Vertex – we have that much firepower …
NICE turns down bone disorder drug for NHS
December 3, 2015Research and Development Alexion, NICE, Strensiq
NICE has published draft guidance as part of its highly specialised technologies programme, not recommending Alexion Pharma’s Strensiq (asfotase alfa) …
GSK collaborates on ‘smart inhaler’ technology for respiratory trials
December 3, 2015Research and Development COPD, GSK, Propeller, Propeller Health, asthma, clinical trials, ellipta, inhalers, smart drugs, smart inhalers
GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …
GSK gets European approval for asthma treatment Nucala
December 3, 2015Research and Development GSK, Nucala, asthma
GlaxoSmithKline has received marketing authorisation from the European Commission for Nucala as an add-on treatment for severe refractory eosinophilic asthma …
Janssen in new collaboration to take on TB
December 3, 2015Research and Development FIND, Janssen, antibiotic resistance, tuberculosis
Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …
Second patient dies in Zafgen obesity trial
December 3, 2015Research and Development
Zafgen has announced the death of a second participant in a Phase III clinical trial of its obesity drug beloranib …
Novo Nordisk buys Xoma diabetes program and scores trial successes
December 2, 2015Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes
Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …
Horizon receives European go-ahead for Ravicti
December 2, 2015Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders
The European Commission has approved Ravicti for rare urea cycle disorders. Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …
Personalised care key to diabetes management, says NICE
December 2, 2015Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes
UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …
Pfizer lung cancer treatment gets expanded EU approval
December 1, 2015Research and Development, Sales and Marketing NSCLC, Pfizer, Xalkori, crizotinib, lung cancer, non-small cell lung cancer
Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …
J&J announces new partnerships in fight against HIV/AIDS
December 1, 2015Research and Development AIDS, HIV, Janssen
Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
PureTech names Nobel Laureate among new members of scientific advisory board
December 1, 2015Medical Communications, Research and Development PureTech Health, puretech
PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team. The scientific …
Investment in pharma manufacturing ‘key to driving UK economy’
December 1, 2015Manufacturing and Production economy, investment, manufacturing, production, robotics
Investing an additional £1.2 billion in UK manufacturing processes to increase robotics and automation could add as much as £60.5bn …
New web portal highlights UK strengths in medicines manufacturing
December 1, 2015Manufacturing and Production ABPI, KTN, Knowledge Transfer Network, Medicines Manufacturing Industry Partnership, UK, manufacturing, mmip, production
A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines …
Collaboration between MPP and University of Liverpool targets HIV nanomedicines
December 1, 2015Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines
The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …
EU approval for Gilead’s HIV combo Genvoya
December 1, 2015Manufacturing and Production, Sales and Marketing European Commission, Genvoya, Gilead, Gilead Sciences, HIV, TDF, World Aids Day, european union, taf
Gilead Sciences has won marketing authorisation from the European Commission (EC) for the once-daily single tablet regimen Genvoya as an …
FDA approves BMS and AbbVie’s Empliciti for multiple myeloma
December 1, 2015Manufacturing and Production, Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Empliciti, FDA, elotuzumab, multiple myeloma
The US healthcare regulator has approved Empliciti – a multiple myeloma treatment co-developed by Bristol-Myers Squibb and AbbVie. The FDA …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
